In addition to BCR-ABL1, by inhibiting VEGFR, FGFR, PDGFR, KIT, and FLT3, it can slow down cancer growth, reduce blood supply to the tumor and help kill cancer cells. This evidence concerns the gene KIT and neoplasm.